POSTER 55

Nemolizumab Long-Term Efficacy and Safety up to 100 Weeks in the OLYMPIA Open-Label Extension Study in Patients with Prurigo Nodularis: An Interim Analysis

Sonja Ständer, Franz J. Legat, Adam Reich, Carle Paul, Dagmar Simon, Luigi Naldi, Gil Yosipovitch, Raja Sivamani, Martin Metz, Aliene Noda, Xiaoxiao Chen, Zarif K. Jabbar-Lopez, Christophe Piketty, Shawn G. Kwatra

< Previous Poster | Next Poster >

Poster 55